BELEZA, SEDUÇÃO E MORTE: Uma leitura exegética de Judite 16,1-12

O cântico de Judite 16,1-12, síntese da parte em prosa do livro, faz memória da ação do Deus de Israel em favor dos oprimidos, libertando-os do poder dos impérios opressores. No centro do poema (v. 5), situa-se a ação do Todo-poderoso por mão de fêmea. A vitória de Judite é uma ironia não só à guerra, mas também às mulheres. Por um lado, as armas utilizadas pela mulher, para matar o comandante-em-chefe beleza do rosto, perfumes, veste festiva, sandália, diadema nos cabelos , são aparentemente insignificantes diante do poderio do exército inimigo, o que representa a vitória dos fracos sobre os fortes. Por outro, numa sociedade patriarcal e androcêntrica, beleza e sedução são consideradas como armas essencialmente femininas. Assim, enquanto a narrativa diverte a audiência, ela adverte aos homens que a mulher bela é perigosa, e, por sua causa, até o general mais poderoso pode perder a cabeça. Entre os séculos 4 a.C. e 2 d.C., há muitas narrativas judaicas que ressaltam o perigo de se olhar para uma mulher bela. No contexto dos movimentos sociais de resistência do período helenista, a literatura historiográfica acentua o protagonismo dos homens, enquanto a ação da mulher como protagonista só aparece no campo da ficção, e ainda para reforçar a atuação masculina. Ler Judite 16,1-12 a partir da ótica de gênero nos desafia a compreender os mecanismos que continuam expropriando o corpo e o desejo de mulheres e homens. É um convite para entoarmos novos cânticos, pautados por relações entre iguais, numa vivência solidária e de reciprocidade.(AU)

Melquisedec, sacerdote de el elyon Uma exegese de Gênesis 14,18-20

Neste estudo, que tem por base Gênesis 14,18-20, se discute a respeito de Melquisedec, o rei de Salém e seu deus el elyon , de quem é sacerdote (v.18). O texto é pós-exílico, sendo uma inserção ao capítulo 14, e reflete a história de Judá no período de sua restauração (séculos 6º a 4º a.C.), numa época em que o sacerdócio de Jerusalém assumiu gradativamente um poder sem precedentes em sua história, de maneira que o sumo-sacerdote acabou por se tornar uma autoridade civil. Melquisedec, que recebe o dízimo de Abrão, é uma imagem que evoca o poder do culto hierosolimitano na sociedade judaíta e seu alegado direito aos dízimos e ofertas oriundos do povo. Mas Melquisedec, usado num texto tardio, pertence a tradições anteriores ao exílio de Judá, segundo as quais o rei também desempenhava papel sacerdotal, como chefe religioso e intendente de Iahweh (Salmo 110). Essa dupla função foi um meio de legitimar as estruturas de poder caracterizadas por uma organização sóciopolítico- econômica que, em aspectos gerais, se ajusta ao conceito de modo de produção tributário. Assim, todo um discurso construído sobre a pessoa do rei e sobre outros aspectos ideológicos, tais quais a teologia de Sião (Salém), serviam de suporte para a manutenção do status quo. E em tal discurso coube o uso do universo simbólico da religião. Neste estudo, aventa-se a hipótese de que el elyon seja um nome composto, no qual subjazem el, que corresponde ao deus supremo do panteão cananeu (o ugarítico ilu), que tem como um de seus atributos o fato de haver gerado céus e terra (o que situa a tradição em concepções cosmogônicas médio-orientais arcaicas); e elyon, o qual parece esconder as características de outro deus, Ba al (Salmo 18, 7-17). Nota-se dessa maneira que o nome do deus de Melquisedec é a combinação sincrética de características de duas grandes divindades do panteão cananeu

Melquisedec, sacerdote de el elyon Uma exegese de Gênesis 14,18-20

Neste estudo, que tem por base Gênesis 14,18-20, se discute a respeito de Melquisedec, o rei de Salém e seu deus el elyon , de quem é sacerdote (v.18). O texto é pós-exílico, sendo uma inserção ao capítulo 14, e reflete a história de Judá no período de sua restauração (séculos 6º a 4º a.C.), numa época em que o sacerdócio de Jerusalém assumiu gradativamente um poder sem precedentes em sua história, de maneira que o sumo-sacerdote acabou por se tornar uma autoridade civil. Melquisedec, que recebe o dízimo de Abrão, é uma imagem que evoca o poder do culto hierosolimitano na sociedade judaíta e seu alegado direito aos dízimos e ofertas oriundos do povo. Mas Melquisedec, usado num texto tardio, pertence a tradições anteriores ao exílio de Judá, segundo as quais o rei também desempenhava papel sacerdotal, como chefe religioso e intendente de Iahweh (Salmo 110). Essa dupla função foi um meio de legitimar as estruturas de poder caracterizadas por uma organização sóciopolítico- econômica que, em aspectos gerais, se ajusta ao conceito de modo de produção tributário. Assim, todo um discurso construído sobre a pessoa do rei e sobre outros aspectos ideológicos, tais quais a teologia de Sião (Salém), serviam de suporte para a manutenção do status quo. E em tal discurso coube o uso do universo simbólico da religião. Neste estudo, aventa-se a hipótese de que el elyon seja um nome composto, no qual subjazem el, que corresponde ao deus supremo do panteão cananeu (o ugarítico ilu), que tem como um de seus atributos o fato de haver gerado céus e terra (o que situa a tradição em concepções cosmogônicas médio-orientais arcaicas); e elyon, o qual parece esconder as características de outro deus, Ba al (Salmo 18, 7-17). Nota-se dessa maneira que o nome do deus de Melquisedec é a combinação sincrética de características de duas grandes divindades do panteão cananeu

Feasibility and utility of population-level geospatial injury profiling : prospective, national cohort study

The Health Services Research Unit receives funding from the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. The opinions expressed in this article are those of the authors alone. The GEOS study was funded by the North of Scotland Planning Group.

Maternal Obesity During Pregnancy Associates With Premature Mortality and Major Cardiovascular Events in Later Life

Acknowledgements We thank Ms Katie Wilde, Data Management Team, University of Aberdeen and Lynsey Waugh, Information and Services Division of NHS Scotland for their help with data extraction and linkage. Funding sources This work was supported by funding from the Chief Scientist Office, Scotland. We also acknowledge support from Tommy’s and the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors are related to any of the funders

In utero exposure to cigarette chemicals induces sex-specific disruption of one-carbon metabolism and DNA methylation in the human fetal liver

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Acknowledgements: We thank Ms Margaret Fraser, Ms Samantha Flannigan, and Dr Wing Yee Kwong for their expert assistance. The staff at Grampian NHS Pregnancy Counselling Service were essential for collecting fetuses. We thank Professor Geoffrey Hammond and Dr Marc Simard, University of British Colombia for helpful comments on the manuscript. Supported by grants as follows: Scottish Senior Clinical Fellowship (AJD); Chief Scientist Office (Scottish Executive, CZG/1/109 to PAF, & CZG/4/742 (PAF & PJOS); NHS Grampian Endowments 08/02 (PAF, SB & PJOS); the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no 212885 (PAF & SMR); the Medical Research Council grants MR/L010011/1 (PAF & PJOS) and MR/K018310/1 (AJD). None of the funding bodies played any role in the design, collection, analysis, and interpretation of data, in the writing of the manuscript, nor in the decision to submit the manuscript for publication

Maternal smoking dysregulates protein expression in second trimester human fetal livers in a sex-specific manner

Acknowledgments The staff at Grampian National Health Service Pregnancy Counseling Service were essential for collecting fetuses. We thank the Aberdeen Proteomics Core Facility (University of Aberdeen) for their expert assistance. Support for the study was provided by the Chief Scientist Office (Scottish Executive, CZG/1/109, & CZG/4/742), National Health Service Grampian Endowments (08/02), the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement no 212885, and the Medical Research Council, UK (MR/L010011/1).

Co-morbidity burden in Parkinson’s disease : Comparison with controls and its influence on prognosis

Open Access funded by Parkinson's UK Financial support: This study was funded by Parkinson’s UK, the Scottish Chief Scientist Office, NHS Grampian endowments, the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, and SPRING. The funders had no involvement in the study. We acknowledge funding for the PINE study from Parkinson’s UK (G-0502, G-0914 G-1302), the Scottish Chief Scientist Office (CAF/12/05), the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, NHS Grampian endowments and SPRING. We thank the patients and controls for their participation and the research staff who collected data and supported the study database.

KDIGO-based acute kidney injury criteria operate differently in hospitals and the community—findings from a large population cohort

ACKNOWLEDGEMENTS We acknowledge the data management support of Grampian Data Safe Haven (DaSH) and the associated financial support of NHS Research Scotland, through NHS Grampian investment in the Grampian DaSH. S.S. is supported by a Clinical Research Training Fellowship from the Wellcome Trust (Ref 102729/Z/13/Z). We also acknowledge the support from The Farr Institute of Health Informatics Research. The Farr Institute is supported by a 10-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates) and the Wellcome Trust (MRC Grant Nos: Scotland MR/K007017/1).

Copy Number Variations in DISC1 and DISC1-Interacting Partners in Major Mental Illness

Acknowledgements We would like to thank all of the patients, relatives and control individuals who participated in the study. We are indebted to the late Prof. Walter Muir, Chair of Developmental Psychiatry and Honorary Consultant in Learning Disability Psychiatry, University of Edinburgh, who initiated these studies and whose work was dedicated to the welfare of the patients who generously participated. We are also grateful to Mrs. Pat Malloy for her assistance with DNA collection and MAQ assays screening of the Scottish samples. The Scottish sample collection was supported by a grant from the Chief Scientist Office (CSO), part of the Scottish Government Health and Social Care Directorates. This research was funded by grants from the CSO to B.S.P. (grant CZB/4/610), The Academy of Medical Sciences/Wellcome Trust to M.J. (grant R41455) and The RS Macdonald Charitable Trust (grant D21419 together with J.H.), the Swedish Research Council (grants 2003-5158 and 2006-4472), the Medical Faculty, Umeå University, and the County Councils of Västerbotten and Norrbotten, Sweden, as well as by grants from the Fund for Scientific Research Flanders (FWO-F), the Industrial Research Fund (IWT) and the Special Research Fund of the University of Antwerp, Belgium. M.J. is funded by a Wellcome Trust Clinical Research Fellowship for MB PhD graduates (R42811). We acknowledge the contribution of the personnel of the VIB Genetic Service Facility (http://www.vibgeneticservicefacility.be/) for the genetic analysis of the Swedish samples. Research nurses Gunnel Johansson, Lotta Kronberg, Tage Johansson and Lisbeth Bertilsson are thankfully acknowledged for their help and expertise. The Betula Study was funded by the Swedish Research Council (grants 345-2003-3883 and 315-2004-6977). We also acknowledge the contribution by the staff in the Betula project

Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12

Funding: British Women’s Heart and Health Study is funded by the Department of Health grant no. 90049 and the British Heart Foundation grant no. PG/09/022. British Regional Heart Study is supported by the British Heart Foundation (grant RG/ 13/16/30528). CB (COPDBEAT) received funding from the Medical Research Council UK (grant no. G0601369), CB (COPDBEAT) and AJW (UKCOPD) were supported by the National Institute for Health Research (NIHR Leicester Biomedical Research Unit). MB (COPDBEAT) received funding from the NIHR (grant no. PDF-2013-06-052). Hertfordshire Cohort Study received support from the Medical Research Council, Arthritis Research UK, the International Osteoporosis Foundation and the British Heart Foundation; NIHR Biomedical Research Centre in Nutrition, University of Southampton; NIHR Musculoskeletal Biomedical Research Unit, University of Oxford. Generation Scotland: Scottish Family Health Study is funded by the Chief Scientist Office, Scottish Government Health Directorates, grant number CZD/16/6 and the Scottish Funding Council grant HR03006. EU COPD Gene Scan is funded by the European Union, grant no. QLG1-CT-2001-01012. English Longitudinal Study of Aging is funded by the Institute of Aging, NIH grant No. AG1764406S1. GoDARTs is funded by the Wellcome Trust grants 072960, 084726 and 104970. MDT has been supported by MRC fellowship G0902313. UK Biobank Lung Exome Variant Evaluation study was funded by a Medical Research Council strategic award to MDT, IPH, DPS and LVW (MC_PC_12010)

Why do health economists promote technology adoption rather than the search for efficiency? A proposal for a change in our approach to economic evaluation in health care

Acknowledgments Financial Support: HERU and HSRU receive a core grant from the Chief Scientist’s Office of the Scottish Government Health and Social Care Directorates, and the Centre for Clinical epidemiology & Evaluation is funded by Vancouver Coastal Health Authority. The model used for the illustrative case study in this paper was developed as part of a NHS Technology Assessment Review, funded by the National Institute for Health Research (NIHR) Health Technology Assessment Program (project number 09/146/01). The views and opinions expressed in this paper are those of the authors and do not necessarily reflect those of the Scottish Government, NHS, Vancouver Coastal Health, NIHR HTA Program or the Department of Health. The authors wish to thank Kathleen Boyd and members of the audience at the UK Health Economists Study Group, for comments received on an earlier version of this paper. We also wish to thank Cynthia Fraser (University of Aberdeen) for literature searches undertaken to inform the manuscript, and Mohsen Sadatsafavi (University of British Columbia) for comments on an earlier draft

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study) : a multicentre, randomised, double-blind trial

Acknowledgments We thank the members of the Trial Steering and Data Monitoring Committee and all the people who helped in the conduct of the study (including the OPPTIMUM collaborative group and other clinicians listed in the appendix). We are grateful to Paul Piette (Besins Healthcare Corporate, Brussels, Belgium) and Besins Healthcare for their kind donation of active and placebo drug for use in the study, and to staff of the pharmacy and research and development departments of the participating hospitals. We are also grateful to the many people who helped in this study but who we have been unable to name, and in particular all the women (and their babies) who participated in OPPTIMUM. OPPTIMUM was funded by the Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council (MRC) and National Institute of Health Research (NIHR) partnership, award number G0700452, revised to 09/800/27. The EME Programme is funded by the MRC and NIHR, with contributions from the Chief Scientist Office in Scotland and National Institute for Social Care and Research in Wales. The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, National Health Service, NIHR, or the Department of Health. The funder had no involvement in data collection, analysis or interpretation, and no role in the writing of this manuscript or the decision to submit for publication.

The thiazide-sensitive Na–Cl cotransporter is an aldosterone-induced protein

Although the collecting duct is regarded as the primary site at which mineralocorticoids regulate renal sodium transport in the kidney, recent evidence points to the distal convoluted tubule as a possible site of mineralocorticoid action. To investigate whether mineralocorticoids regulate the expression of the thiazide-sensitive Na–Cl cotransporter (TSC), the chief apical sodium entry pathway of distal convoluted tubule cells, we prepared an affinity-purified, peptide-directed antibody to TSC. On immunoblots, the antibody recognized a prominent 165-kDa band in membrane fractions from the renal cortex but not from the renal medulla. Immunofluorescence immunocytochemistry showed TSC labeling only in distal convoluted tubule cells. Semiquantitative immunoblotting studies demonstrated a large increase in TSC expression in the renal cortex of rats on a low-NaCl diet (207 ± 21% of control diet). Immunofluorescence localization in tissue sections confirmed the strong increase in TSC expression. Treatment of rats for 10 days with a continuous subcutaneous infusion of aldosterone also increased TSC expression (380 ± 58% of controls). Furthermore, 7-day treatment of rats with an orally administered mineralocorticoid, fludrocortisone, increased TSC expression (656 ± 114% of controls). We conclude that the distal convoluted tubule is an important site of action of the mineralocorticoid aldosterone, which strongly up-regulates the expression of TSC.

Studying Early Nodulin Gene ENOD40 Expression and Induction by Nodulation Factor and Cytokinin in Transgenic Alfalfa1

ENOD40, an early nodulin gene, is expressed following inoculation with Rhizobium meliloti or by adding R. meliloti-produced nodulation (Nod) factors or the plant hormone cytokinin to uninoculated roots. We isolated two MsENOD40 clones, designated MsENOD40–1 and MsENOD40–2, with distinct promoters from an alfalfa (Medicago sativa cv Chief) genomic library. The promoters were fused to the reporter gene uidA (gus), and the constructs were introduced into alfalfa. We observed that the MsENOD40–1 construct was expressed almost exclusively under symbiotic conditions. The MsENOD40–2 construct was transcribed under both symbiotic and nonsymbiotic conditions and in nonnodular and nodular tissues. Both MsENOD40 promoter-gus constructs were similarly expressed as nodules developed, and both were expressed in roots treated with 6-benzylaminopurine or purified Nod factor. However, no blue color was detected in nodule-like structures induced by the auxin transport inhibitor N-1-(naphthyl)phthalamic acid on roots of plants containing the MsENOD40–1 promoter construct, whereas pseudonodules from plants containing the MsENOD40–2 promoter construct stained blue. A 616-bp region at the distal 5′ end of the promoter is important for proper spatial expression of MsENOD40 in nodules and also for Nod-factor and cytokinin-induced expression.